EZH2 overexpression leads to the development of atherosclerosis in ApoE−/− mice by catalyzing the methylation of DNMT1-mediated ATP binding cassette transporter A1, thereby inhibiting macrophage cholesterol efflux and promoting foam cell formation (87). Here, EZH2 is linked to atherosclerosis.